II. Epidemiology
- Incidence: 1% of women
III. Pathophysiology
- Follicle depletion or dysfunction resulting in impaired ovarian function
IV. Causes
- Idiopathic (>90%)
- Chromosomal Abnormality- X-Chromosome abnormality (e.g. Turner Syndrome)
- Y-Chromosome presence abnormality
 
- Infection (e.g. Mumps)
- Autoimmune Disease directed at Ovary
- Empty Sella Syndrome
- Chemotherapy or Radiation Exposure related
V. Associated Conditions
- FMR1 Gene premutation- Associated with risk of Fragile X Syndrome in children
 
- 
                          Thyroid autoimmune disorders- Consider testing for Thyroid autoantibodies
 
- Adrenal autoimmune disorders- Consider testing for adrenal autoantibodies
 
- 
                          Turner Syndrome
                          - May present only as Short Stature and Amenorrhea
- Obtain karyotype from women with Short Stature and Primary Ovarian Insufficiency- Multi-system implications of Turner Syndrome require surveillance and highlight the importance of testing
 
 
VI. Diagnosis
- Follicle Stimulating Hormone in menopausal range on 2 consecutive tests, one month apart AND
- Woman younger than age 40 years old with Amenorrhea or Oligomenorrhea
VII. Symptoms
VIII. Labs
- See Secondary Amenorrhea
- See Markers of Ovarian Reserve
- Anti-Mullerian Hormone
- 
                          Follicle Stimulating Hormone
                          - Used as part of diagnosis above
 
IX. Labs: As Indicated for secondary cause
- Fasting Serum Glucose
- Calcium
- Phosphorus
- Total Protein
- Albumin to globulin ratio
- Complete Blood Count (CBC)
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Antinuclear Antibody (ANA)
- Thyroid Stimulating Hormone (TSH)
- Morning Serum Cortisol Level
- Consider Karyotype
X. Management
- 
                          Osteoporosis Prevention
                          - Calcium Supplementation 1200 mg daily
- Vitamin D Supplementation 800 IU daily (or more)
 
- Estrogen Replacement Therapy
- Pregnancy- Risk of variable fertility (10% have spontaneous resolution and risk of pregnancy)- Consider combined Hormonal Contraception instead of Estrogen Replacement to prevent pregnancy
 
- Otherwise pregnancy is possible with donor implantation
 
- Risk of variable fertility (10% have spontaneous resolution and risk of pregnancy)
